Epidemiology of hepatitis C in Croatia in the European context
- PMID: 26327756
- PMCID: PMC4548109
- DOI: 10.3748/wjg.v21.i32.9476
Epidemiology of hepatitis C in Croatia in the European context
Abstract
We analyzed prevalence, risk factors and hepatitis C virus (HCV) genotype distribution in different population groups in Croatia in the context of HCV epidemiology in Europe, with the aim to gather all existing information on HCV infection in Croatia which will be used to advise upon preventive measures. It is estimated that 35000-45000 of the Croatian population is chronically infected with HCV. Like in other European countries, there have been changes in the HCV epidemiology in Croatia over the past few decades. In some risk groups (polytransfused and hemodialysis patients), a significant decrease in the HCV prevalence was observed after the introduction of routine HCV screening of blood/blood products in 1992. Injecting drug users (IDUs) still represent a group with the highest risk for HCV infection with prevalence ranging from 29% to 65%. Compared to the prevalence in the Croatian general population (0.9%), higher prevalence rates were found in prison populations (8.3%-44%), human immunodeficiency virus-infected patients (15%), persons with high-risk sexual behavior (4.6%) and alcohol abusers (2.4%). Low/very low prevalence was reported in children and adolescents (0.3%) as well as in blood donors (0%-0.009%). In addition, distribution of HCV genotypes has changed due to different routes of transmission. In the general population, genotypes 1 and 3 are most widely distributed (60.4%-79.8% and 12.9%-47.9%, respectively). The similar genotype distribution is found in groups with high-risk sexual behavior. Genotype 3 is predominant in Croatian IDUs (60.5%-83.9%) while in the prison population genotypes 3 and 1 are equally distributed (52.4% and 47.6%). Data on HCV prevalence and risk factors for transmission are useful for implementation of preventive measures and HCV screening.
Keywords: Croatia; Europe; Genotypes; Hepatitis C; Seroprevalence.
Figures


Similar articles
-
[Epidemiology of viral hepatitis].Acta Med Croatica. 2013 Oct;67(4):273-9. Acta Med Croatica. 2013. PMID: 24984326 Croatian.
-
Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia.J Med Virol. 2009 Aug;81(8):1348-53. doi: 10.1002/jmv.21530. J Med Virol. 2009. PMID: 19551819
-
Low prevalence of hepatitis C virus infection among human immunodeficiency virus type 1-infected individuals from Slovenia and Croatia.Acta Virol. 2002;46(2):91-4. Acta Virol. 2002. PMID: 12387500
-
Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review.J Clin Lab Anal. 2019 Jun;33(5):e22876. doi: 10.1002/jcla.22876. Epub 2019 Mar 7. J Clin Lab Anal. 2019. PMID: 30843304 Free PMC article.
-
Epidemiology of hepatitis C virus in Iran.World J Gastroenterol. 2015 Oct 14;21(38):10790-810. doi: 10.3748/wjg.v21.i38.10790. World J Gastroenterol. 2015. PMID: 26478671 Free PMC article. Review.
Cited by
-
How close are we to hepatitis C virus elimination in Central Europe?Clin Exp Hepatol. 2020 Feb;6(1):1-8. doi: 10.5114/ceh.2020.93049. Epub 2020 Feb 17. Clin Exp Hepatol. 2020. PMID: 32166117 Free PMC article.
-
HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons.Viruses. 2022 Feb 26;14(3):482. doi: 10.3390/v14030482. Viruses. 2022. PMID: 35336889 Free PMC article. Review.
-
Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia.Infect Dis Rep. 2020 Nov 11;12(3):74-81. doi: 10.3390/idr12030016. Infect Dis Rep. 2020. PMID: 33187150 Free PMC article.
-
Hepatotropic viruses: Is Roma population at risk?World J Gastroenterol. 2021 Jan 14;27(2):143-151. doi: 10.3748/wjg.v27.i2.143. World J Gastroenterol. 2021. PMID: 33510555 Free PMC article. Review.
-
Seroprevalence Trends and Molecular Epidemiology of Viral Hepatitis in Croatia.Life (Basel). 2023 Jan 13;13(1):224. doi: 10.3390/life13010224. Life (Basel). 2023. PMID: 36676173 Free PMC article. Review.
References
-
- WHO/Europe. Hepatitis: data and statistics. Available from: http://www.euro.who.int/en/health-topics/communicable-diseases/hepatitis....
-
- Muga R, Sanvisens A, Bolao F, Tor J, Santesmases J, Pujol R, Tural C, Langohr K, Rey-Joly C, Muñoz A. Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001. Drug Alcohol Depend. 2006;82 Suppl 1:S29–S33. - PubMed
-
- Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction. 2009;104:1881–1890. - PMC - PubMed
-
- Quer J, Esteban Mur JI. Epidemiology and prevention. In: Thomas HC, Lok ASF, Locarnini A, Zuckerman A, editors. Viral hepatitis. 4th ed. Chichester: JohnWiley & Sons; 2014. pp. 256–265.
-
- Dentico P, Volpe A, Buongiorno R, Carlone A, Carbone M, Manno M. Hepatitis C virus in hemodialysis patients. Nephron. 1992;61:307–308. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous